- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Bayer CEO Bill Anderson took pay cut in 2024 as company kicked off 3-year restructuring | ||
| Fr | AstraZeneca touts disease recurrence win, 'strong trend' in survival benefit for Imfinzi in early stomach cancer | ||
| Fr | Vertex puts patient's story at heart of National Kidney Month awareness drive | ||
| Do | In confirmation hearing, FDA nominee Martin Makary talks drug reviews, vaccines, ethics and more | ||
| Do | In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight | ||
| Do | In UK, it's strike 2 for Alzheimer's treatments from Lilly and Biogen/Eisai | ||
| Do | Pfizer, BioNTech notch US win-and loss in Germany-amid high-stakes patent fight with Moderna | ||
| Do | As chikungunya launch looms, Bavarian Nordic CEO tips travel health to become the company's dominant business | ||
| 05.03. | Leo Pharma, awaiting FDA approval decision, finds dermatologists are frustrated with current chronic hand eczema treatments | ||
| 05.03. | Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients | ||
| 05.03. | As Xarelto's decline picks up speed, Bayer doesn't expect pharma growth until 2027 | ||
| 05.03. | Lilly's 1st DTC Ebglyss campaign highlights eczema's effects on a range of skin tones and age groups | ||
| 05.03. | Want a piece of Lilly's $27B US manufacturing investment? Please send your application | ||
| 05.03. | CordenPharma to build €500M Swiss peptide plant, generating 300 new jobs | ||
| 05.03. | FDA blasts Edenbridge over 'misleading' exhibit booth panel | ||
| 05.03. | After peptide expansion, Axplora hits the gas to boost ADC capacity at French facility | ||
| 04.03. | Want HCPs' attention? Here's what drug marketing messages resonate and when | ||
| 04.03. | Gilead sets aside $200M for potential settlement over HIV drug speaker program | ||
| 04.03. | Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits | ||
| 04.03. | As Gardasil underwhelms, Merck lights up landmarks in China in HPV awareness day push | ||
| 04.03. | Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug | ||
| 04.03. | Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site | ||
| 03.03. | Pfizer could shift overseas production to US if Trump's pharma tariffs take hold, CEO says | ||
| 03.03. | AstraZeneca, Daiichi unblind Enhertu study early as star ADC helps stomach cancer patients live longer | ||
| 03.03. | Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
